Problem:Obstructive sleep apnea in obesity

From Pharmacopedia

Revision as of 06:03, 13 June 2026 by MDElliottMD (talk | contribs) (Launch A7: honest early-note placeholder (mark-tapped))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Nav

This page is early; a full clinical description is coming. The cross-linked medicines below are live.

Moderate-to-severe obstructive sleep apnea in adults with obesity. Basis for the 2024 tirzepatide (Zepbound) OSA approval following SURMOUNT-OSA.

Medicines used for Obstructive sleep apnea in obesity

Tirzepatide

Retrieved from "https://pharmacopedia.wiki/index.php?title=Problem:Obstructive_sleep_apnea_in_obesity&oldid=7601"